About Merck (MSD)
Industry:
Pharmaceuticals
Founded:
1891
Founders:
George Merck
Status:
Public (NYSE: MRK)
Funding & Growth
Total Raised:
N/A
Valuation:
$280B+ market cap
Stage:
Public
Key Investors:
Public markets
✓ Pros
- • Keytruda success
- • Strong oncology focus
- • Good work-life balance
- • Excellent benefits
- • Research-focused culture
✗ Cons
- • New Jersey location
- • Large company processes
- • Can be slow moving
- • Keytruda dependency